Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2030774
Max Phase: Preclinical
Molecular Formula: C26H35FN4O6
Molecular Weight: 518.59
Molecule Type: Small molecule
Associated Items:
ID: ALA2030774
Max Phase: Preclinical
Molecular Formula: C26H35FN4O6
Molecular Weight: 518.59
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)NC[C@H]1CN(c2ccc(N3CCC4(CC3)C3CCC4N(C(=O)OC(C)(C)C)O3)c(F)c2)C(=O)O1
Standard InChI: InChI=1S/C26H35FN4O6/c1-16(32)28-14-18-15-30(23(33)35-18)17-5-6-20(19(27)13-17)29-11-9-26(10-12-29)21-7-8-22(26)37-31(21)24(34)36-25(2,3)4/h5-6,13,18,21-22H,7-12,14-15H2,1-4H3,(H,28,32)/t18-,21?,22?/m0/s1
Standard InChI Key: CLLQCZDASJZQQE-XTWGIRIWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 518.59 | Molecular Weight (Monoisotopic): 518.2541 | AlogP: 3.59 | #Rotatable Bonds: 4 |
Polar Surface Area: 100.65 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 1.52 | CX LogP: 2.53 | CX LogD: 2.53 |
Aromatic Rings: 1 | Heavy Atoms: 37 | QED Weighted: 0.65 | Np Likeness Score: -0.69 |
1. Ji C, Lin W, Moraski GC, Thanassi JA, Pucci MJ, Franzblau SG, Möllmann U, Miller MJ.. (2012) Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction., 20 (11): [PMID:22560837] [10.1016/j.bmc.2012.04.026] |
Source(1):